Volume | 0 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Cocrystal Pharma Inc | COCP | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
1.48 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 1.325 - 3.285 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
- | 0 | $ 1.48 | USD |
Cocrystal Pharma Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
15.06M | 10.17M | - | 0 | -38.84M | -3.82 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Cocrystal Pharma News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical COCP Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.43 | 1.56 | 1.416 | 1.48 | 12,911 | 0.05 | 3.50% |
1 Month | 1.47 | 1.58 | 1.325 | 1.48 | 13,316 | 0.01 | 0.68% |
3 Months | 1.79 | 1.89 | 1.325 | 1.58 | 12,291 | -0.31 | -17.32% |
6 Months | 2.00 | 2.18 | 1.325 | 1.72 | 16,384 | -0.52 | -26.00% |
1 Year | 1.87 | 3.285 | 1.325 | 2.21 | 34,203 | -0.39 | -20.86% |
3 Years | 18.00 | 41.52 | 1.325 | 19.13 | 1,864,054 | -16.52 | -91.78% |
5 Years | 34.56 | 49.20 | 1.325 | 18.87 | 2,049,098 | -33.08 | -95.72% |
Cocrystal Pharma Description
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. The company employs structure-based technologies and Nobel Prize-winning expertise to create first-and best-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). |